Search for: "ASTRAZENECA LP"
Results 41 - 60
of 138
Sorted by Relevance
|
Sort by Date
12 Feb 2018, 12:05 pm
According to that JPML Transfer Order the Defendants -- AstraZeneca Pharmaceuticals LP, Bristol-Myers Squibb Co., and McKesson Corp. -- opposed centralization of approximately 80 Onglyza and Kombiglyze lawsuits into this new MDL: Defendants oppose transfer by arguing that plaintiffs’ allegations are supported by a single study (the SAVOR study), which itself supports only claims regarding heart failure – not the various other injuries (congestive heart failure, acute… [read post]
16 Apr 2010, 3:30 am
AstraZeneca Pharmaceuticals, LP, 2010 WL 1267219 (Del. [read post]
27 Feb 2012, 3:30 am
AstraZeneca Pharmaceuticals, LP, No. 1:10CV104-SA-JAD, 2010 WL 3951906 (N.D. [read post]
28 Sep 2009, 9:56 pm
Sometimes, Sins of Omission Are Not Inequitable Conduct By Kevin E. [read post]
11 Mar 2011, 11:46 am
AstraZeneca Pharmaceuticals LP, 2011 WL 833222, slip op. (11th Cir. [read post]
12 Jun 2008, 4:45 am
Omeprazole is the active ingredient in Prilosec ®, which is marketed by Plaintiffs-Appellants Astrazeneca, AB, Aktiebolaget Hassle, KBI-E, Inc., KBI, Inc., and Astrazeneca LP (Astrazeneca) for the treatment of gastric and duodenal ulcers, and which acts by inhibiting the production of gastric acid. [read post]
8 Feb 2009, 9:35 pm
AstraZeneca Pharmaceuticals LP, No. 6:07-cv-15733-Orl-22DAB, slip op. [read post]
11 Dec 2011, 9:00 pm
AstraZeneca Pharmaceuticals LP, the Federal Circuit explained when a secret invention can be considered "made" (or conceived and reduced to practice) so that it can be used as prior art against a patent. [read post]
11 Dec 2011, 9:00 pm
AstraZeneca Pharmaceuticals LP, the Federal Circuit explained when a secret invention can be considered "made" (or conceived and reduced to practice) so that it can be used as prior art against a patent. [read post]
19 Oct 2023, 4:00 am
AstraZeneca Pharmaceuticals LP, (D MD, Oct. 17, 2023), a Maryland federal district court dismissed a Title VII religious discrimination claim by two employees who were denied a religious exemption from a company's Covid vaccine mandate, finding that their objections were not religious in nature. [read post]
15 Apr 2016, 8:26 am
These medications are available by prescription and over-the-counter (OTC) from various pharmaceutical companies, for example: PRILOSEC (omeprazole magnesium) | prescription drug | AstraZeneca LPPRILOSEC OTC (omeprazole magnesium) | over-the-counter | Procter & Gamble Manufacturing Co.PREVACID (lansoprazole) | prescription drug | Takeda Pharmaceuticals America, Inc.PREVACID 24 HR (lansoprazole) | over-the-counter | Novartis Consumer Health, Inc.NEXIUM (esomeprazole magnesium) |… [read post]
25 May 2009, 4:56 am
AstraZeneca LP, 605 F.Supp.2d 669, 2009 WL 827920, *1 (W.D.Pa. 2009). [read post]
30 Nov 2012, 7:45 am
No. 10-915-LPS (D. [read post]
27 Feb 2015, 5:02 am
AstraZeneca to Pay $7.9 Million to Resolve Kickback Allegations AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Claims Act. [read post]
29 Aug 2016, 12:30 pm
For use as an example, here is the relevant part of an August 17, 2016 FDA Supplemental Approval letter to AstraZeneca Pharmaceuticals LP for Farxiga: Please refer to your supplemental New Drug Application (sNDA) dated and received July 28 2016, submitted under section 505(b) of the Federal Food, Drug, and Cosmetic Act (FDCA) for Farxiga (dapagliflozin) tablets. [read post]
20 Apr 2012, 10:36 am
McGrath In its recent decision in AstraZeneca Pharmaceuticals LP v. [read post]
27 May 2009, 12:44 am
"AstraZeneca LP v. [read post]
3 Oct 2010, 8:57 pm
Astrazeneca Pharmaceuticals LP... [read post]
29 Nov 2012, 5:21 am
No. 10-915-LPS (D. [read post]
26 Mar 2012, 1:43 am
District Court for the District of Columbia denied AstraZeneca Pharmaceuticals LP’s (“AstraZeneca’s”) Application for Prelimiary Injunction and dismissed without prejudice the action AstraZeneca filed on March 12, 2012 seeking to enjoing FDA from granting final ANDA approval for a generic version of the company’s blockbuster antipsychotic drug SEROQUEL (quetiapine fumarate) Tablets (NDA No. 020639) as early as March 26, 2012 (as well… [read post]
